RT Journal Article
T1 Non-Invasive Assessment of Pulmonary Vasculopathy
A1 Ponz, Ines
A1 Nuche, Jorge
A1 Sánchez Sánchez, Violeta
A1 Sánchez González, Javier
A1 Blázquez Bermejo, Zorba
A1 Caravaca Pérez, Pedro
A1 García Cosio Carmena, Maria Dolores
A1 Juan Baguda, Javier S. De
A1 Rodríguez Chaverri, Adriana Rodríguez
A1 Sarnago Cebada, Fernando
A1 Arribas Ynsaurriaga, Fernando
A1 Ibañez, Borja
A1 Delgado Jiménez, Juan Francisco
AB Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibility and prognostic relevance of a non-invasive evaluation of the pulmonary artery vasculature in patients with heart failure and pulmonary hypertension. Patients will undergo a right heart catheterization, cardiac resonance imaging, and a pulmonary function test in order to identify structural and functional parameters allowing the identification of combined pre- and postcapillary pulmonary hypertension, and correlate these findings with the hemodynamic data.
PB MPDI
SN 2673-3846
YR 2021
FD 2021-01-05
LK https://hdl.handle.net/20.500.14352/7057
UL https://hdl.handle.net/20.500.14352/7057
LA eng
NO Ponz, I., Nuche, J., Sánchez Sánchez, V. et al. «Non-Invasive Assessment of Pulmonary Vasculopathy». Hearts, vol. 2, n.o 1, enero de 2021, pp. 5-14. DOI.org (Crossref), https://doi.org/10.3390/hearts2010002.
NO Instituto de Salud Carlos III/Fondo Europeo de Desarrollo Regional
DS Docta Complutense
RD 9 abr 2025